Sponsor pipeline

Aplagon Oy clinical trial pipeline

Get alerts when Aplagon Oy's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor

    Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting

    Aplagon OyEarly Phase 1 NCT06204237 Registry history

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT07352800 Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial… Peripheral Arterial Occlusive Disease Recruiting 2026-04-09
Get alerts when Aplagon Oy's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free